Kinnate Biopharma Inc. Closes $35 Million Series A Financing to Establish a Chinese Joint Venture
May 13, 2021 16:02 ET
|
Kinnate Biopharma
Financing led by OrbiMed Asia Partners, with participation from OrbiMed Private Investments and Foresite CapitalThe joint venture will have exclusive license to develop and commercialize Kinnate’s...
TELA Bio Announces First Quarter 2021 Financial Results
May 13, 2021 16:02 ET
|
TELA Bio, Inc.
MALVERN, Pa., May 13, 2021 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA") (Nasdaq: TELA), a commercial stage medical technology company focused on designing, developing, and marketing innovative tissue...
Sprouts Farmers Market to Present at the BMO Capital Markets 16th Annual Farm to Market Virtual Conference
May 13, 2021 16:02 ET
|
Sprouts Farmers Market
PHOENIX, May 13, 2021 (GLOBE NEWSWIRE) -- Sprouts Farmers Market, Inc. (Nasdaq: SFM) today announced that Jack Sinclair, chief executive officer, and Denise Paulonis, chief financial officer, will...
Equillium Reports First Quarter 2021 Financial Results and Provides Clinical Development Update
May 13, 2021 16:02 ET
|
Equillium
Announced favorable data from Phase 1b EQUALISE study in patients with systemic lupus erythematosus Cash runway into the second half of 2023 Multiple data and regulatory catalysts through the...
PRA Health Sciences利用Synoma率先实现临床试验患者与其现实数据相连接
May 13, 2021 16:02 ET
|
PRA Health Sciences, Inc.
北卡罗来纳州罗利市, May 14, 2021 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. （NASDAQ:...
PRA Health Sciences pioneers connecting clinical trial patients with their real-world data with Synoma
May 13, 2021 16:02 ET
|
PRA Health Sciences, Inc.
RALEIGH, N.C., May 13, 2021 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ: PRAH) announced today an innovative tokenization solution using Synoma®, PRA’s proprietary technology that allows...
Nkarta Reports First Quarter 2021 Financial Results and Business Progress
May 13, 2021 16:02 ET
|
Nkarta, Inc.
NKX019 IND received FDA clearance; NKX019 patient dosing expected to start in 2H 2021Protocol amendment to ongoing NKX101 clinical trial adds a second multi-dosing regimen and a shorter waiting period...
Athira Pharma Reports First Quarter 2021 Financial Results and Provides Business Highlights
May 13, 2021 16:02 ET
|
Athira Pharma, Inc.
-Phase 2 trial initiation for Parkinson’s disease dementia program and IND submission for neuropsychiatric program planned by end of 2021- -Hosted educational webinar on targeting HGF/MET...
Accumulus Synergy nomme Francisco Nogueira au poste de président-directeur général
May 13, 2021 16:01 ET
|
Accumulus Synergy
BURLINGAME, Californie, 13 mai 2021 (GLOBE NEWSWIRE) -- Accumulus Synergy, une société à but non lucratif visant à soutenir les interactions entre les autorités de l'industrie et de la santé dans le...
Prometheus Biosciences Reports First Quarter 2021 Financial Results and Provides a Corporate Update
May 13, 2021 16:01 ET
|
Prometheus Biosciences
-PRA023, an anti-TL1A mAb, on track to initiate Phase 2 study for Ulcerative Colitis and Phase 2a study for Crohn’s Disease in 3Q 2021- -Launched Prometheus Enroll360™, a global patient recruitment...